Skip to main content

Advertisement

Table 10 Unadjusted estimated effect of treatment on hemorrhagic complications

From: Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

  Unadjusted OR (95 % CI) p-value
Fondaparinux vs. variable dose warfarin Both 1.29 (0.61-2.71) 0.709
  Hip 0.45 (0.14-1.42) 0.236
  Knee 3.18 (1.07-9.45) 0.034
Fixed dose warfarin vs. variable dose warfarin Both 0.83 (0.38-1.84) 0.854
  Hip 0.38 (0.12-1.24) 0.134
  Knee 1.78 (0.57-5.62) 0.463
Fixed dose warfarin vs. fondaparinux Both 0.65 (0.30-1.40) 0.384
  Hip 0.84 (0.23-3.10) 0.946
  Knee 0.56 (0.21-1.47) 0.338